Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)

NCT02477319 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT02477319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02477319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Two-Part Multicenter Prospective Longitudinal Study of CFTR-dependent Disease Profiling in Cystic Fibrosis (PROSPECT)
Lead sponsor
University of Alabama at Birmingham
Phase
Observational
Overall status
Completed
Start date
March 31, 2015
Completion date
July 27, 2018
Enrollment
452 (actual)
Sites
38

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis